Results 61 to 70 of about 555,640 (280)

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

open access: yesMolecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son   +13 more
wiley   +1 more source

BaroFuse, a novel pressure-driven, adjustable-throughput perfusion system for tissue maintenance and assessment

open access: yesHeliyon, 2016
Objectives: Microfluidic perfusion systems are used for assessing cell and tissue function while assuring cellular viability. Low perfusate flow rates, desired both for conserving reagents and for extending the number of channels and duration of ...
Austin Rountree   +5 more
doaj   +1 more source

METHODS OF ORGANIZING AND CONDUCTING LABORATORY WORK IN TEACHING PHARMACEUTICAL CHEMISTRY FOR STUDENTS MAJORING IN «PHARMACY, INDUSTRIAL PHARMACY»

open access: yesНеперервна професійна освіта: теорія та практика, 2022
The relevance of the scientific topic is based on finding and solving the problems of selecting and improving the methodology of organization and conducting laboratory work in the teaching of pharmaceutical chemistry for students of the «Pharmacy ...
Galina Rizak
doaj   +1 more source

Structure prediction of transferrin receptor protein 1 (TfR1) by homology modelling, docking, and molecular dynamics simulation studies

open access: yesHeliyon, 2020
Transferrin receptor protein 1 (TfR1) is an important molecule in anti-cancer therapy. Targeted delivery of such therapeutic compounds improves their cellular uptake and circulation time, thereby enhancing therapeutic efficacy.
Maha Ateeq AL-Refaei   +2 more
doaj   +1 more source

Tailored novel phosphonate-based hybrid materials by design for diverse applications [PDF]

open access: yes, 2018
Hybrid materials are composed of an organic and an inorganic part, placed together in such a way that the final product has defined structures and properties.
Demadis, Konstantinos D.
core  

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

open access: yesMolecular Oncology, EarlyView.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat   +18 more
wiley   +1 more source

Salmon cartilage proteoglycan promotes the healing process of Staphylococcus aureus-infected wound

open access: yesHeliyon, 2018
Wound healing is the critical event for maintaining skin function and barrier. Inflammatory state in which a variety of cells are activated and accumulated is important for wound healing.
Shouhei Hirose   +3 more
doaj   +1 more source

$\mathcal{G}$-SELC: Optimization by sequential elimination of level combinations using genetic algorithms and Gaussian processes

open access: yes, 2009
Identifying promising compounds from a vast collection of feasible compounds is an important and yet challenging problem in the pharmaceutical industry.
Mandal, Abhyuday   +2 more
core   +1 more source

Similarity-based data mining in files of two-dimensional chemical structures using fingerprint measures of molecular resemblance [PDF]

open access: yes, 2011
This paper reviews the use of measures of intermolecular similarity for processing databases of chemical structures, which play an important role in the discovery of new drugs by the pharmaceutical industry.
Willett, P.
core   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy